Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Cassava Sciences Inc (SAVA)
Cassava Sciences Inc (SAVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 878,484
  • Shares Outstanding, K 42,174
  • Annual Sales, $ 0 K
  • Annual Income, $ -76,250 K
  • 60-Month Beta 0.02
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.61
Trade SAVA with:

Options Overview Details

View History
  • Implied Volatility 73.71% ( -0.63%)
  • Historical Volatility 105.21%
  • IV Percentile 13%
  • IV Rank 7.46%
  • IV High 169.12% on 01/03/23
  • IV Low 66.02% on 03/14/23
  • Put/Call Vol Ratio 1.05
  • Today's Volume 3,657
  • Volume Avg (30-Day) 6,112
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 124,395
  • Open Int (30-Day) 142,056

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.40
  • Number of Estimates 1
  • High Estimate -0.40
  • Low Estimate -0.40
  • Prior Year -0.47
  • Growth Rate Est. (year over year) +14.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.20 +8.33%
on 11/13/23
25.46 -18.30%
on 11/03/23
-0.75 (-3.48%)
since 11/01/23
3-Month
12.32 +68.83%
on 10/13/23
25.46 -18.30%
on 11/03/23
-0.24 (-1.14%)
since 09/01/23
52-Week
12.32 +68.83%
on 10/13/23
45.43 -54.21%
on 12/14/22
-13.34 (-39.07%)
since 12/01/22

Most Recent Stories

More News
1 Big Red Flag to Fear When a Stock Is Down

Playing the blame game does not make for an effective turnaround strategy.

SAVA : 20.80 (-0.14%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA). Such...

SAVA : 20.80 (-0.14%)
Why Cassava Sciences Stock Is Tanking Today

Investors are worried about a leaked report related to alleged data manipulation for Cassava's Alzheimer's disease treatment candidate.

SAVA : 20.80 (-0.14%)
Why Shares of Cassava Sciences Soared This Week

Cassava bounced back from hitting a 52-week low to start the week.

SAVA : 20.80 (-0.14%)
Why Shares of Cassava Sciences Are Dropping Wednesday

The company announced phase 3 trial results for its lead Alzheimer's therapy.

LLY : 584.04 (-1.18%)
SAVA : 20.80 (-0.14%)
Why Shares of Cassava Sciences Jumped This Week

Cassava Sciences finished dosing in one of its phase 3 trials for its Alzheimer's therapy Simufilam.

SAVA : 20.80 (-0.14%)
Stock Index Futures Move Lower As Fed Jitters Persist

March S&P 500 futures (ESH23) are down -0.38%, and March Nasdaq 100 E-Mini futures (NQH23) are down -0.68% this morning after three major U.S. benchmark indices ended the regular session mixed as market...

ESH23 : 3,957.05s (-0.09%)
NQZ23 : 16,023.75s (+0.24%)
LEG.D.DX : 72.940 (+3.96%)
AM.FP : 184.100 (+0.93%)
SI : 1.2500 (+0.81%)
SIVB : 106.04 (-60.41%)
ASAN : 22.46 (+6.90%)
SAVA : 20.80 (-0.14%)
MDB : 435.23 (+4.69%)
H : 118.10 (+2.91%)
3 Big Reasons to Sell Cassava Sciences Stock Right Now

It isn't about running out of money, but it's still laden with risk.

SAVA : 20.80 (-0.14%)
Cassava Sciences Stock Undervalued with Its $124 Price Target?

Casava Sciences Inc (NASDAQ: SAVA) stock has been the topic of much controversy in its quest for FDA approval for its simufilam drug. The Company is a

SAVA : 20.80 (-0.14%)
BIIB : 234.64 (+0.24%)
MRK : 103.46 (+0.96%)
LLY : 584.04 (-1.18%)
AZN : 64.79 (+0.31%)
Is Mesa Laboratories (MLAB) Outperforming Other Medical Stocks This Year?

Here is how Mesa Labs (MLAB) and Cassava Sciences, Inc. (SAVA) have performed compared to their sector so far this year.

MLAB : 90.37 (+5.86%)
SAVA : 20.80 (-0.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 21.81
2nd Resistance Point 21.55
1st Resistance Point 21.18
Last Price 20.80
1st Support Level 20.55
2nd Support Level 20.29
3rd Support Level 19.92

See More

52-Week High 45.43
Fibonacci 61.8% 32.78
Fibonacci 50% 28.87
Fibonacci 38.2% 24.97
Last Price 20.80
52-Week Low 12.32

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar